Meanwhile, statins accelerated c-Myc degradation and inhibited c-Myc protein synthesis, indicating that statins interfere with c-Myc biosynthesis, which exists not only in chemotherapy-sensitive ovarian cancer cells but also in multi-chemo-resistant cells. This evidence concerns the gene MYC and ovarian carcinoma.